Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 03:18:18 +0200Thu, 27 Jun 2024 13:24:00 +0200Zeposia: EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4835-en_2.pdfZeposia: EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4835-en_2.pdfThu, 27 Jun 2024 13:24:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 7, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zeposiaHuman medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 7, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zeposiaThu, 27 Jun 2024 12:14:00 +0200Human medicine